ProfileGDS4132 / 204389_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 29% 93% 93% 27% 30% 28% 29% 81% 90% 29% 35% 92% 92% 30% 35% 33% 36% 89% 88% 40% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10169.93929
GSM201543Muscle PCOS pioglitazone 121474.43493
GSM201544Muscle PCOS pioglitazone 161591.5893
GSM201545Muscle PCOS pioglitazone 20170.627
GSM201829Muscle PCOS pioglitazone 23178.521230
GSM201830Muscle PCOS pioglitazon 25171.188928
GSM201831Muscle PCOS pioglitazone 27168.845229
GSM201832Muscle PCOS pioglitazone 31274.02381
GSM201833Muscle PCOS pioglitazone 41445.36890
GSM201834Muscle PCOS pioglitazone 8167.934529
GSM201835Muscle PCOS after pioglitazone 10275.117135
GSM201836Muscle PCOS after pioglitazone 122523.37392
GSM201837Muscle PCOS after pioglitazone 162517.78892
GSM201838Muscle PCOS after pioglitazone 20266.269430
GSM201839Muscle PCOS after pioglitazone 23282.389335
GSM201840Muscle PCOS after pioglitazone 25278.190633
GSM201841Muscle PCOS after pioglitazone 27275.896336
GSM201842Muscle PCOS after pioglitazone 32392.89789
GSM201843Muscle PCOS after pioglitazone 42387.20688
GSM201844Muscle PCOS after pioglitazone 8299.530940